WHO warns of contaminated India cough syrups
Oct 14 (Reuters) – The WHO (World Health Organization) on Monday issued a health advisory warning about three contaminated cough syrups identified in India, urging authorities to report any detection of these medicines in their countries to the health agency. The WHO said the affected medicines are specific batches of Coldrif from Sresan Pharmaceutical, Respifresh TR from Rednex Pharmaceuticals and ReLife from Shape Pharma. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. The agency said the contaminated products pose significant risks and can cause severe, potentially life-threatening illness. India’s